These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 919441)
1. [Effectiveness of inosine derivatives in patients with ischemic heart disease]. Kuz'ko NV Vrach Delo; 1977 Aug; (8):25-8. PubMed ID: 919441 [No Abstract] [Full Text] [Related]
2. [Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease]. Kuz'ko NV Vrach Delo; 1988 Oct; (10):16-9. PubMed ID: 3218185 [No Abstract] [Full Text] [Related]
3. [Use of riboxin in treating patients with chronic ischemic heart disease]. Lanovaia NI; Neĭko EM Vrach Delo; 1986 Aug; (8):17-9. PubMed ID: 3776150 [No Abstract] [Full Text] [Related]
4. [Inosine. II. Perspectives of its use in cardiological diagnosis and therapy]. Czarnecki W Kardiol Pol; 1982; 25(7-8):639-45. PubMed ID: 6763102 [No Abstract] [Full Text] [Related]
5. [Experience in the use of the Soviet drug riboxin in therapeutic practice]. Komarov FI; Ol'binskaia LI; Vartanova OA; Ovchinnikova LV; Pogromov AP Sov Med; 1979 Dec; (12):82-3. PubMed ID: 531611 [No Abstract] [Full Text] [Related]
6. Restoration of function in ischaemic myocardium by inosine [proceedings]. Kingaby RO; Lab MJ; Woollard K J Physiol; 1977 Oct; 272(1):102P-103P. PubMed ID: 592116 [No Abstract] [Full Text] [Related]
7. [Phonomechanocardiographic evaluation of the effect of inosine on the function of the left ventricle in patients with chronic coronary insufficiency]. Ortiz J; Winter HE; Barreto AC; Tranchesi J; Pileggi F; Rangel FA; Del Nero E Arq Bras Cardiol; 1975 Jun; 28(3):361-7. PubMed ID: 1180717 [No Abstract] [Full Text] [Related]
8. [Effectiveness of the use of rauwolfia derivatives in patients with ischemic heart disease]. Kuz'ko NV Vrach Delo; 1975 Jun; (6):49-52. PubMed ID: 1154737 [No Abstract] [Full Text] [Related]
9. [Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease]. Bondarenko IP Vrach Delo; 1983 Jan; (1):15-8. PubMed ID: 6868490 [No Abstract] [Full Text] [Related]
12. [Effect of inosine on the course of myocardial infarct]. Nikolaeva LF; Lysenko LT; Makarova TE Klin Med (Mosk); 1975 Jul; 53(7):50-6. PubMed ID: 1206993 [No Abstract] [Full Text] [Related]
13. [Anti-arrhythmic effectiveness of isoptin in ischemic heart disease in the middle-aged and elderly]. Korkushko OV; Sarkisov KG; Butenko AG Vrach Delo; 1980 Jan; (1):30-5. PubMed ID: 7376578 [No Abstract] [Full Text] [Related]
14. [Effectiveness of small doses of heparin in ischemic heart disease]. Doroshenko GL Vrach Delo; 1973 Nov; 11():27-30. PubMed ID: 4786926 [No Abstract] [Full Text] [Related]
15. [Evaluation of the effectiveness of Nitro-Mac retard forte in ischemic heart disease]. Zamotaev IP; Venediktova MG; Lozinskiĭ LG; Mktrchian VR Sov Med; 1989; (12):44-6. PubMed ID: 2517154 [No Abstract] [Full Text] [Related]
16. [Effectiveness of using prolonged-action nitrates in ischemic heart disease]. Kuz'ko NV Vrach Delo; 1981 Sep; (9):24-7. PubMed ID: 6795823 [No Abstract] [Full Text] [Related]
17. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270 [No Abstract] [Full Text] [Related]